Tempus
AI-powered precision medicine, genomic testing, and clinical data analytics
AI-Powered Summary
Tempus is a precision medicine company that uses AI and large-scale clinical data analysis to support cancer treatment decisions, drug development, and clinical research. It combines genomic sequencing, digital pathology, EHR data, and machine learning models to provide actionable insights to oncologists, health systems, and pharmaceutical companies. The platform operates globally across 50+ countries and has recently expanded into digital pathology through its acquisition of Paige.
Key Features
What makes Tempus stand out
Genomic Profiling
Comprehensive genomic sequencing tests to identify actionable mutations for cancer treatment.
AI Clinical Co-Pilot
David, a generative AI assistant, integrates into EHR platforms to help clinicians with treatment decisions.
Digital Pathology
AI-powered pathology analysis through the acquired Paige platform for tissue slide interpretation.
Real-World Data Products
Curated, analysis-ready multimodal datasets for drug development and outcomes research.
Clinical Trial Network
The TIME Trial Network accelerates patient enrollment and trial execution for pharma partners.
ECG AI Analysis
FDA-cleared software that uses AI to detect patients with low left ventricular ejection fraction from ECGs.
AI Data Abstraction
Agentic AI architecture transforms unstructured clinical text into structured, analysis-ready data at scale.
Mortality Endpoint Modeling
Validated composite mortality endpoint that overcomes EHR data fragmentation for real-world evidence studies.
What's Great
- One of the largest multimodal clinical datasets combining genomics, imaging, and EHR data
- FDA-cleared AI products (ECG-Low EF software) add regulatory credibility
- Generative AI co-pilot (David) integrates directly into hospital EHR systems like at Northwestern Medicine
- Global presence in 50+ countries with multiple US labs and offices
- Acquisition of Paige strengthens digital pathology capabilities significantly
Things to Know
- No publicly available pricing — requires enterprise-level sales engagement
- Primarily focused on oncology, limiting utility for non-cancer healthcare applications
- Complexity of offerings may be overwhelming for smaller clinics or independent practitioners
Pricing Plans
All Tempus pricing tiers and features
Pricing is not publicly listed; contact sales for quotes
Enterprise / Custom
Real Cost Breakdown
Hidden Costs
- Per-test genomic profiling costs may be significant depending on test volume
- Data licensing fees for real-world data products are negotiated separately
- Integration and onboarding for EHR co-pilot (David) may require additional implementation costs
Cost Saving Tips
- Engage with Tempus sales early to understand bundled pricing for multiple products
- Health systems may negotiate volume discounts for genomic testing
Tempus is an enterprise-grade precision medicine platform with no public pricing; it serves large health systems and pharma companies with custom contracts likely in the six-to-seven-figure annual range.
Price Comparison
Compare Tempus with similar tools
Tempus offers enterprise pricing. Contact their sales team for a custom quote based on your needs.
Best For
Oncologists, health systems, and pharma companies needing genomic data-driven insights
Who Should NOT Use This
- Individual consumers seeking personal health testing — Tempus is designed for healthcare providers, health systems, and pharma companies — not direct-to-consumer personal genomics like 23andMe.
- Small independent clinics with no oncology focus — The platform is heavily oriented toward oncology and complex data-driven precision medicine, which may be far beyond the needs and budgets of small general practices.
- Startups or small biotech firms with limited budgets — Tempus operates on enterprise-level custom pricing with no self-serve or free tier, making it inaccessible for organizations with constrained research budgets.
- Software developers looking for a healthcare API to build apps — Tempus is not a developer platform or API-first product; it provides clinical and data science services rather than self-service developer tools.
Competitive Position
Tempus uniquely combines one of the largest multimodal clinical datasets with AI applications spanning genomics, digital pathology, and a generative AI EHR co-pilot, all under one platform.
When to Choose Tempus
- When you need a comprehensive multimodal dataset combining genomics, pathology, and EHR data for oncology research
- When you want an AI co-pilot that integrates directly into your health system's EHR
- When you're a pharma company looking to accelerate clinical trial enrollment with real-world data matching
- When you need FDA-cleared AI diagnostic tools alongside genomic profiling
When to Look Elsewhere
- When you need affordable, self-service consumer genomic testing
- When your focus is on non-oncology specialties with no plans to expand
- When you need a lightweight, plug-and-play diagnostic tool without enterprise integration
- When budget constraints prevent enterprise-level data licensing agreements
Strongest alternative: Foundation Medicine (Roche)
Learning Curve
Prerequisites
Common Challenges
- Understanding the breadth of Tempus' product portfolio and which solutions apply to specific use cases
- Integrating AI tools into existing clinical workflows and EHR systems
- Interpreting multimodal genomic and clinical data outputs without specialized training
Frequently Asked Questions
Common questions about Tempus
Compare Tempus
See how Tempus stacks up against alternatives
Ready to try Tempus?
Join thousands of users who are already using Tempus to supercharge their workflow.
Get Started Free